Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
07/2001
07/05/2001DE19964116A1 Increasing bioavailability of magnesium ions by co-administration of vitamin K, allowing reduction of dosage in the treatment of magnesium deficiency syndrome
07/05/2001CA2395950A1 Cells capable of differentiating into heart muscle cells
07/04/2001EP1113007A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
07/04/2001EP1112744A1 Zinc oxide as plasminogen activator inhibitor for external use
07/04/2001EP1112741A1 Use of protease inhibitors for the treatment of necrotizing infections
07/04/2001EP1112271A1 Ergoline amine derivatives with blood pressure lowering effect
07/04/2001EP1112178A1 Method for treating calcium borate ores to obtain useful boron compounds
07/04/2001EP1112063A1 Lipstatin derivative-soluble fiber tablets
07/04/2001EP1112003A2 Composition comprising a viscosity modulating polymer material and its use
07/04/2001EP1111995A1 Topical dermal antimicrobial compositions
07/04/2001CN1302207A Combined therapy for bipolar disorders
07/04/2001CN1302201A Ophthalmic compositions containing galactomannan polymers and borate
07/04/2001CN1301547A Analgesic plaster for osteoarthritis
07/04/2001CN1301537A Liniment for skin disease and use
07/04/2001CN1067902C Decrustation ointment for burn and its preparing process
07/04/2001CN1067896C Externally used medicine for fishes
07/04/2001CN1067895C Chinese and western medicinal preparation for curing hand and foot tinea and preparing method thereof
07/04/2001CN1067889C Traditional Chinese Medicine compound disinfactant
07/04/2001CN1067885C Burn curing powder
07/04/2001CN1067879C Preparation for curing dermatomycosis
07/04/2001CN1067877C Medicinal composition for curing scald
07/04/2001CN1067876C Protective film of preparation for rumen
07/04/2001CN1067868C Composition containing reading absorbable calcium and process for producing the same
07/04/2001CN1067867C Preparation of health salt
07/03/2001USRE37263 Topically applying two solutions, gels or creams one of a metal chlorite and thickener and one of a protic acid and thickener
07/03/2001US6255341 Nutrients; mixture of vitamins, triglycerides and protein
07/03/2001US6255277 Localized use of nitric oxide-adducts to prevent internal tissue damage
07/03/2001US6254893 Calcium-based ophthalmic composition including a hydrophobic carrier, such as petrolatum, and a calcium salt, sufficiently viscous to prevent dripping or running after application to the skin adjacent the eyelids
07/03/2001US6254881 Treatment of infections in mammary glands
07/03/2001US6254853 Drugs with carriers
07/03/2001CA2098108C Water dispersible tablets
06/2001
06/29/2001CA2293913A1 Treatment of necrotizing infections
06/28/2001WO2001045753A1 Apparatus and method of treatment of wounds, burns and immune system disorders
06/28/2001WO2001045717A2 Pharmaceutical composition comprising a vanadium compound and at least a component selected from a na+/h+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors
06/28/2001WO2001045716A1 Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and a na+/h+ exchange inhibitor
06/28/2001WO2001045701A1 Natural extracted and synthetic antioxidant compositions
06/28/2001WO2000076454A3 Therapeutic compositions for ophthalmic use and therapeutic compositions for brain central lesions
06/28/2001WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
06/28/2001WO2000042987A8 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
06/28/2001WO1999000112A8 Sucralfate-containing composition and process for the preparation thereof
06/28/2001US20010005510 Anti-fungal composition
06/28/2001US20010005502 Monofluoro phosphorylated macromolecules
06/28/2001CA2394635A1 Apparatus and method of treatment of wounds, burns and immune system disorders
06/28/2001CA2394330A1 Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and at least a component selected from a na+/h+ exchanger inhibitors, cyclo-oxygenase inhibitors and caspase inhibitors
06/27/2001EP1109562A1 Composite biocidal particles
06/27/2001EP1109548A1 Compositions and methods for treating and preventing bone diseases using tocotrienols
06/27/2001EP1109534A1 Quick release pharmaceutical compositions of drug substances
06/27/2001EP0806953B1 Agent for acting upon bone formation disturbances containing potassium citrates, lactates and/or malates
06/27/2001CN1301169A Adenovirus-chemotherapeutic combination for treating cancer
06/27/2001CN1300614A Medicine for treating trigeminal neuralgia
06/27/2001CN1300601A Recovery capsule for hepatitis and its preparing process
06/27/2001CN1300599A Process for extracting active iodine from kelp
06/27/2001CN1300597A Composition for treating cancer by magnetic positioning and its preparing process
06/27/2001CN1300596A Dual-nm material for treatint cancer by magnetic positioning and its preparing process
06/27/2001CN1300575A Towel for taking care of skin health
06/27/2001CN1067583C Chinese medicine for treating piles and its preparation
06/27/2001CN1067580C Medicinal composition for treating recurrent aphthae
06/27/2001CN1067572C Sprayed powder for treating macerative erosive beriberi
06/27/2001CN1067564C Medical ointment for burn and scald
06/27/2001CN1067550C Calcium receptor active molecules
06/26/2001US6253104 Method of preparing pharmaceutical Moxa extract and apparatus for electrical moxibustion using the same extract
06/26/2001US6251927 Treating sickle cell anemia using protected forms of organic aldehydes
06/26/2001US6251439 Composition and method for reducing the risk of carcinogenesis
06/26/2001US6251380 Extraction of plants with methanol, dichloromethane, ethyl acetate, mixing and drying then dilution
06/26/2001US6251369 Dental fluoride foam
06/26/2001US6251365 Magnetite monocrystals and phosphatide membranes
06/26/2001US6251355 Fine cisplatin powder and process for the production thereof
06/24/2001CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
06/21/2001WO2001043725A1 Controlled release kci tablet formulations
06/21/2001WO2001043710A1 Monofluoro phosphorylated macromolecules
06/21/2001WO2001010411A3 Implantable active ingredient depot
06/21/2001WO2000061191A9 Heat stable coated colloidal iron oxides
06/21/2001CA2394588A1 Controlled release kcl tablet formulations
06/20/2001EP1107826A1 Device for micronizing materials
06/20/2001EP1107795A2 Methods and compositions for the prevention or treatment of cancer
06/20/2001EP1107784A2 Activation and protection of t-cells (cd4?+ and cd8?+ ) using an h 2? receptor agonist and other t-cell activating agents
06/20/2001EP1107775A1 Composition containing pyrrolizidine-alkaloid-free petasites
06/20/2001EP1107767A2 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
06/20/2001EP1107766A2 Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis
06/20/2001EP1107751A2 Medicament containing platinum complex compounds and the use thereof
06/20/2001EP1107732A1 Oral liquid mucoadhesive compositions
06/20/2001CN1299677A Cancer treating Tibetans medicine and its preparation
06/20/2001CN1299675A Gargle for treating toothache
06/20/2001CN1299673A Preparation of cancer treating medicine capsule
06/20/2001CN1299668A Multifunctional calcium tablet and its production process
06/19/2001US6248718 Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity
06/19/2001US6248375 Food bar
06/19/2001US6248371 Tuberculosis
06/19/2001US6248370 Skin treatment and methods
06/19/2001US6248368 Administering magnesium salt
06/19/2001US6248347 Calcium assimilation accelerator and calcium-supplementing diet comprising and a method for accelerating calcium assimilation
06/19/2001US6248335 Ph control
06/19/2001CA2172187C Method of incorporating drugs into a polymer component of stents
06/19/2001CA2021116C Topical compositions containing live yeast cell derivative and other topically active medicinal ingredients
06/14/2001WO2001041774A1 Haemostatic bactericidal compositions
06/14/2001WO2001041766A1 The combination of a serotonin reuptake inhibitor and irindalone
06/14/2001WO2001041733A2 Compressed tablet composition comprising a nsaid
06/14/2001WO2001041701A2 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist
06/14/2001WO2001041651A2 Microdermabrasion device
06/14/2001WO2001028552A3 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts